Beam Therapeutics Inc. - BEAM

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$2.91B

QoQ value delta ($000)

-$128.7M (-4.24%)

Implied price effect (QoQ)

-12.79%

Total shares

120,350,631

QoQ shares delta

+10,750,759 (+9.81%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 250 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
FMR LLC	296,735	12,452,199	0.02%
ARK Investment Management LLC	289,139	12,133,433	2.25%
VANGUARD GROUP INC	254,843	9,193,474	0.0%
FARALLON CAPITAL MANAGEMENT LLC	241,509	10,134,696	1.38%
BlackRock, Inc.	202,258	8,487,569	0.0%
STATE STREET CORP	135,813	5,699,265	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	108,922	4,570,797	0.01%
ARCH Venture Management, LLC	108,191	4,540,132	15.98%
VANGUARD CAPITAL MANAGEMENT LLC	104,312	4,377,374	0.0%
Sumitomo Mitsui Trust Group, Inc.	91,163	3,825,585	0.06%
Amova Asset Management Americas, Inc.	91,163	3,825,585	1.29%
Kynam Capital Management, LP	87,746	3,682,185	5.41%
PRICE T ROWE ASSOCIATES INC /MD/	64,658	2,713,230	0.01%
GEODE CAPITAL MANAGEMENT, LLC	57,647	2,418,592	0.0%
DIMENSIONAL FUND ADVISORS LP	51,326	2,154,575	0.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	39,408	1,653,714	0.01%
MWG Caph Ltd	35,119	1,266,934	48.53%
ADAR1 Capital Management, LLC	34,467	1,446,375	2.03%
Casdin Capital, LLC	32,170	1,350,000	2.44%
Redmile Group, LLC	29,493	1,237,659	1.95%
TWO SIGMA INVESTMENTS, LP	28,854	1,210,853	0.02%
Qube Research & Technologies Ltd	25,850	1,084,768	0.03%
GOLDMAN SACHS GROUP INC	23,966	1,005,743	0.0%
UBS Group AG	19,685	826,061	0.0%
NORTHERN TRUST CORP	19,673	825,580	0.0%